The Portable Bioprocessing Bioreactors Market is anticipated to flourish at a healthy CAGR of 14.6% between 2023 and 2033. The market is expected to hold a market share of USD 6.75 billion by 2033 while the market is likely to reach a value of USD 1.73 billion in 2023.
Attribute | Details |
---|---|
Portable Bioprocessing Bioreactors Market CAGR (2023 to 2033) | 14.6% |
Portable Bioprocessing Bioreactors Market Size (2023) | USD 1.73 billion |
Portable Bioprocessing Bioreactors Market Size (2033) | USD 6.75 billion |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The key driver of the demand for portable bioprocessing bioreactors is exponential growth in the biopharmaceutical industry, and there is a lot of research work happening in this area. Moreover, numerous advancements are made in the area of biotechnology and related field. This is expected to surge the sales of portable bioprocessing bioreactors.
Portable bioprocessing bioreactors occupy less floor space, as a result of which they help in the storage of other important medical devices as well, which is not the case if we use conventional bioprocessing bioreactors. This might lead to an increase in the adoption of portable bioprocessing bioreactors.
The application of portable bioprocessing bioreactors also reduces the risk of contamination, which is commonly observed while using conventional bioprocessing bioreactors. This is expected to surge the portable bioprocessing bioreactors market share.
The usage of portable bioprocessing bioreactors provides control over various parameters like temperature, pH, moisture level, oxygen, and stirring rate to help maximize the growth rate of the cell. This is expected to increase the demand for portable bioprocessing bioreactors.
One of the challenges that are being faced in this market is the lack of skilled professionals. The portable bioprocessing bioreactor is a relatively sophisticated and new product.
This leads to the fact that the professionals are found only in developed regions, and there is an acute shortage of such professionals in other regions.
Additionally, the maintenance cost associated with portable bioprocessing bioreactors is quite high, and the biopharmaceutical centers might have to bear a high cost for the service and maintenance of these bioreactors.
Countries | Revenue Share % (2022) |
---|---|
The United States | 26.3% |
Germany | 5.8% |
Japan | 5.9% |
North America | 31.5% |
Europe | 23.5% |
Countries | CAGR % (2023 to 2033) |
---|---|
China | 18.4% |
India | 17.8% |
Australia | 9.9% |
North America held a market share of 31.5% in 2022 and it is the largest market for portable bioprocessing bioreactors. During the forecast period, the region is expected to dominate the market.
Notable advancements in technology and the biopharmaceutical sector in this region are expected to be the reasons why North America is projected to be the leading market. Moreover, the ability to manage the expenses related to maintaining portable bioprocessing bioreactors is another reason why North America is touted to be the leading market.
Europe, which held a market share of 23.5% in 2022 and is expected to be one of the significantly-growing markets for portable bioprocessing bioreactors during the forecast period.
People in Europe are particularly cautious when it comes to cleanliness around them. The usage of portable bioprocessing bioreactors ensures almost no contamination. Moreover, the ability to simulate the required conditions is expected to surge the portable bioprocessing bioreactors market size in the region.
Category | By Material Type |
---|---|
Leading Segment | Single |
Market Share (2022) | 41.30% |
Category | By End User Type |
---|---|
Leading Segment | Biopharmaceutical Industry |
Market Share (2022) | 47.60% |
Based on material type, the single segment flourishes as it held a market share of 41.30% in 2022. The end user category is dominated by the biopharmaceutical industry with a share of 47.60% in 2022.
The start-up space in the market is implementing methods to make these bioreactors effective with the demand for an efficient way of conducting research in the field of biotechnology, and the ability to automate the process,
Some of the start-ups operating in this niche are PharSol, AUCTEQ Biosystems, ReaGenics, and Fermex Solutions. Moreover, the start-ups are mainly working toward building miniaturized bioreactors.
These are automated, stirred tank reactors that run perfusion cultures using little culture media, and these require a short set-up time. Also, start-ups are developing photobioreactors that enable the culture of phototrophic organisms. These supply light and carbon dioxide to growing plants.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Some of the key players in the portable bioprocessing bioreactors market are Thermo Fisher Scientific, Merck & Co. Inc., Sartorius Stedim Biotech SA, Uma Pharmatech machinery, IKA, Biosan, GE Healthcare, Parker Hannifin Corp, and Avantor Fluid Handling LLC.
The key market players are mainly focusing on further developing the bioreactors. These bioreactors might enable the reproducible and standardized cultivation of a wide variety of cell types and are bound to raise bars with their ergonomic and efficient operation.
Recent Developments:
The market is valued at USD 173.0 billion in 2023.
GE Healthcare, Biosan, and IKA are key market players.
The biopharmaceutical sector is extensively favored in application category.
The market in India is likely to record a CAGR of 17.8% through 2033.
India, Japan, and China dominate the Asian market.
1. Executive Summary 2. Market Overview 3. Market Background 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Capacity 5.1. 1-10 L 5.2. 10-50 L 5.3. 50-100 L 5.4. 100-500 L 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User 6.1. Biopharmaceuticals Industry 6.2. Academic Institute 6.3. Research Laboratories 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Material 7.1. Glass 7.2. Stainless Steel 7.3. Single Use 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Control Type 8.1. Automatic 8.2. Manual 9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Suppliers 9.1. Original Equipment Manufacturers 9.2. System Integrators 9.3. Engineering Procurement and Construction 10. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 10.1. North America 10.2. Latin America 10.3. Western Europe 10.4. Eastern Europe 10.5. South Asia and Pacific 10.6. East Asia 10.7. Middle East and Africa 11. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 16. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 17. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 18. Key Countries Market Analysis 19. Market Structure Analysis 20. Competition Analysis 20.1. Thermo Fisher Scientific 20.2. Merck & Co. Inc. 20.3. Sartorius Stedim Biotech SA 20.4. Uma Pharmatech Machinery 20.5. IKA 20.6. Biosan 20.7. GE Healthcare 20.8. Parker Hannifin Corp 20.9. Avantor Fluid Handling LLC 20.10. BioProcessors Corporation 21. Assumptions & Acronyms Used 22. Research Methodology
Explore Healthcare Insights
View Reports